RaDiCo-GenIDA
Paris, Île-de-France Region, 75012, France
Location status: Recruiting
Location contact
Jean-Louis Mandel, Pr
PRINCIPAL_INVESTIGATOR
Sonia Gueguen, PHD
CONTACT
NCT Number: NCT06871696
The aim of this observational study is to develop an alternative database model for genetically originated intellectual disabilities. This model will take the form of an online cohort study, where the majority of clinical information will be provided by the families of the patients. Questionnaires developed by professionals but formulated in a way understandable to families will be used to gather this information.
Specifically, this study aims to collect relevant information for personalized medical management. This includes understanding the risks of specific pathological complications and potential iatrogenic effects of symptomatic treatments. The primary goal is to establish groups of individuals with intellectual disabilities and/or autism spectrum disorders (ASD) sharing the same genetic mutation. This approach will provide a better understanding of the natural history of the disease and associated comorbidities.
It is important to note that this project will only focus on patients for whom the identification of the causal mutation or penetrant copy number variation (CNV) has been determined. It excludes individuals for whom the cause of intellectual disability is unknown.
This approach will contribute to a better understanding of the genetic aspects of intellectual disabilities and ASD, while facilitating more targeted and personalized medical care for the affected patients.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Paris, Île-de-France Region, 75012, France
Location status: Recruiting
Jean-Louis Mandel, Pr
PRINCIPAL_INVESTIGATOR
Sonia Gueguen, PHD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
There are no restrictions based on age, gender, or potential comorbidities of the individual themselves.
Exclusion criteria
Time frame: Day 1, Every 6 months over 5 years
Time frame: Day 1, Every 6 months over 5 years
Time frame: Day 1, Every 6 months over 5 years
Time frame: Day 1, Every 6 months over 5 years
Contact information is provided by the study sponsor or research team.
Institut National de la Santé Et de la Recherche Médicale, France
Other Gov
Genetic of Intellectual Deficiency and Autism Spectrum Disorders
Acronym: RaDiCo-GenIDA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03718923
Autism Spectrum Disorder, Child Development Disorders, Pervasive
New York, United States
View Trial DetailsNCT06740162
Abnormalities, Multiple, Aniridia
Fayetteville, Arkansas, United States
View Trial DetailsNCT07278544
Autism Spectrum Disorder, Behavior
Athens, Georgia, United States
View Trial DetailsNCT03492060
Autism Spectrum Disorder, Child Development Disorders, Pervasive
New York, United States
View Trial Details